This is a routine filing with no trading implications. Monitor the next 6-K or 20-F for any substantive operational or clinical updates regarding ATH434 or the company's cash position.
Price Chart
Executive Summary
Alterity Therapeutics filed a Form 6-K on October 23, 2026, solely to submit an Exhibit 99.1 notification regarding unquoted securities (ATH). The filing contains no new material financial, operational, or clinical information. It is a routine administrative submission with no substantive disclosure.
Key Facts
- Filed Form 6-K on October 23, 2026, for the month of October 2026.
- Exhibit 99.1 is a notification regarding unquoted securities - ATH.
- No financial results, guidance, clinical updates, or material agreements disclosed.
- The filing is incorporated by reference into existing S-8 and F-3 registration statements.
Financial Impact
No financial impact; filing is administrative with no new financial data.
Risk Factors
- No new information provided; the filing does not address the going concern risk disclosed in the prior 20-F.
- The company's cash burn and need for additional capital remain unchanged.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001437749-26-033317 |
| Document: 0001437749-26-033317-index-headers.html | 0001437749-26-033317 |
| Document: 0001437749-26-033317-index.html | 0001437749-26-033317 |
| Document: 0001437749-26-033317.txt | 0001437749-26-033317 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.08 (+0.48%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.08 (−0.48%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.08 (−0.48%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.08 (−12.97%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.08 (−12.97%) |
Oct 19, 2026 8d ago | 6-K | $2.43 | awaiting T+60 | — | $2.08 (−14.40%) |
Oct 9, 2026 18d ago | 6-K | $3.12 | awaiting T+60 | — | $2.08 (−33.33%) |
Oct 5, 2026 21d ago | Press Release | $3.22 | awaiting T+60 | — | $2.08 (−35.40%) |
Oct 5, 2026 22d ago | 6-K | $3.22 | awaiting T+60 | — | $2.08 (−35.40%) |
Sep 25, 2026 4w ago | 6-K | $3.67 | awaiting T+60 | — | $2.08 (−43.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers